|
Ref21C13
Therapeutic
and Antilipoperoxidant Effects of Silibyn-Phosphatidylcholine
Complex (Siliphos®) in Chronic Liver Disease:
Preliminary Results
S.
Moscarella1, A. Giusti1, F. Marra1, C. Marena2, M. Lampertico2,
P. Relli1, P. Gentilini1 and G. Buzzelli1
Institute of Clinica Medica II, University of Florence, Florence,
Italy and 2Medical Department, Inverna della Beffa, Milan, Italy
Journal not listed on Medline
Eight
patients (two men and six women), with viral chronic active
hepatitis were treated with (Siliphos®) for two months.
After treatment, serum malondialdehyde levels decreased by 36%
(which indicates significantly less liver damage) and the quantitiative
liver function evaluation increased by 15% (which is quite dramatic).
A statistically significant reduction of transaminases was also
seen. These results indicate (Siliphos®) is effective in
improving the biochemical and quantitative indices of hepatic
function in patients with chronic active hepatitis.
Ref21C13
|
|
